Ascendis Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	75,191	65,619	41,303	35,713	34,253	36,943
Market Cap Growth	-	58.87%	15.65%	4.26%	-7.28%	-17.80%
Enterprise Value	77,064	64,262	40,288	34,735	32,896	33,613
PS Ratio	14.44	15.49	21.77	24.16	124.47	833.13
PB Ratio	25.62	-68.52	-74.90	-44.23	24.19	7.33
P/TBV Ratio	9.93	-79.37	-75.40	-48.66	26.01	8.34
P/FCF Ratio	277.83	245.65	-	-	-	-
P/OCF Ratio	206.66	206.98	-	-	-	-
EV/Sales Ratio	15.39	15.17	21.24	23.50	119.53	758.03
EV/FCF Ratio	284.75	240.57	-	-	-	-
Debt / Equity Ratio	0.79	-2.37	-3.45	-1.53	1.83	0.11
Debt / EBITDA Ratio	87.54	-	-	-	-	-
Debt / FCF Ratio	19.93	19.20	-	-	-	-
Net Debt / Equity Ratio	0.66	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	31.62	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	7.20	5.63	-0.97	-0.52	0.45	1.31
Asset Turnover	0.52	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	-0.10	0.32	0.18	-0.26	0.12	0.09
Quick Ratio	0.68	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.00	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	305.05%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	1.30%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	2.21%	-26.11%	-66.04%	-158.18%	-190.06%	-154.96%
Return on Capital Employed (ROCE)	-1.31%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
FCF Yield	0.36%	0.41%	-	-	-	-
Buyback Yield / Dilution	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.